SIGVARIS Launches New Compression Therapy Designed to Promote Diabetic Wellness

PEACHTREE CITY, Ga. (Jan. 28, 2015)—For patients with diabetes, finding the right socks and footwear can often be a challenge. SIGVARIS is taking steps to make it easier with a new compression therapy designed to provide therapeutic relief for diabetic patients.

Constructed with patented drirelease yarns and an embedded FreshGuard technology treatment, SIGVARIS Eversoft Diabetic Socks wick away moisture and prevent odor, thus reducing friction against the skin and lowering the risk of infection, and provide graduated compression that improves circulation.

“By creating the most innovative products with the finest textiles available, SIGVARIS has quickly become a trusted name in compression therapy for diabetic patients,” says David Rosenberg, director of marketing for SIGVARIS North America. “Patients who try Eversoft Diabetic Socks will be taking steps to improve their overall health, well being and activity level.”

SIGVARIS first introduced diabetic patients to the health benefits of graduated compression therapy several years ago with the launch of the SIGVARIS Diabetic Compression Socks. With the launch of the new Eversoft Diabetic Socks, physicians will now be able to determine whether a patient needs a light (8-15mmHg) or a moderate (18-25mmHg) compression level and be able to prescribe the SIGVARIS compression therapy that best suits the individual need. Visit sigvarisusa.com.